206 related articles for article (PubMed ID: 28060481)
1. Mechanism of the Association Pathways for a Pair of Fast and Slow Binding Ligands of HIV-1 Protease.
Huang YM; Raymundo MA; Chen W; Chang CA
Biochemistry; 2017 Mar; 56(9):1311-1323. PubMed ID: 28060481
[TBL] [Abstract][Full Text] [Related]
2. Ritonavir and xk263 Binding-Unbinding with HIV-1 Protease: Pathways, Energy and Comparison.
Sun J; Raymundo MAV; Chang CA
Life (Basel); 2022 Jan; 12(1):. PubMed ID: 35054509
[TBL] [Abstract][Full Text] [Related]
3. Switches of hydrogen bonds during ligand-protein association processes determine binding kinetics.
Huang YM; Kang M; Chang CE
J Mol Recognit; 2014 Sep; 27(9):537-48. PubMed ID: 25042708
[TBL] [Abstract][Full Text] [Related]
4. Binding pathways of ligands to HIV-1 protease: coarse-grained and atomistic simulations.
Chang CE; Trylska J; Tozzini V; McCammon JA
Chem Biol Drug Des; 2007 Jan; 69(1):5-13. PubMed ID: 17313452
[TBL] [Abstract][Full Text] [Related]
5. Insights into the dynamics of HIV-1 protease: a kinetic network model constructed from atomistic simulations.
Deng NJ; Zheng W; Gallicchio E; Levy RM
J Am Chem Soc; 2011 Jun; 133(24):9387-94. PubMed ID: 21561098
[TBL] [Abstract][Full Text] [Related]
6. Explicit solvent dynamics and energetics of HIV-1 protease flap opening and closing.
Sadiq SK; De Fabritiis G
Proteins; 2010 Nov; 78(14):2873-85. PubMed ID: 20715057
[TBL] [Abstract][Full Text] [Related]
7. Substrate binding mechanism of HIV-1 protease from explicit-solvent atomistic simulations.
Pietrucci F; Marinelli F; Carloni P; Laio A
J Am Chem Soc; 2009 Aug; 131(33):11811-8. PubMed ID: 19645490
[TBL] [Abstract][Full Text] [Related]
8. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
9. Binding to the open conformation of HIV-1 protease.
Lexa KW; Carlson HA
Proteins; 2011 Jul; 79(7):2282-90. PubMed ID: 21604303
[TBL] [Abstract][Full Text] [Related]
10. Ligand Binding Pathways and Conformational Transitions of the HIV Protease.
Miao Y; Huang YM; Walker RC; McCammon JA; Chang CA
Biochemistry; 2018 Mar; 57(9):1533-1541. PubMed ID: 29394043
[TBL] [Abstract][Full Text] [Related]
11. Dynamic flaps in HIV-1 protease adopt unique ordering at different stages in the catalytic cycle.
Karthik S; Senapati S
Proteins; 2011 Jun; 79(6):1830-40. PubMed ID: 21465560
[TBL] [Abstract][Full Text] [Related]
12. Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights.
Chetty S; Bhakat S; Martin AJ; Soliman ME
J Biomol Struct Dyn; 2016; 34(1):135-51. PubMed ID: 25671669
[TBL] [Abstract][Full Text] [Related]
13. Binding free energy contributions of interfacial waters in HIV-1 protease/inhibitor complexes.
Lu Y; Yang CY; Wang S
J Am Chem Soc; 2006 Sep; 128(36):11830-9. PubMed ID: 16953623
[TBL] [Abstract][Full Text] [Related]
14. Kinetic characterization of the critical step in HIV-1 protease maturation.
Sadiq SK; Noé F; De Fabritiis G
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20449-54. PubMed ID: 23184967
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanics Study of Flow and Surface Influence in Ligand-Protein Association.
Kaushik S; Chang CA
Front Mol Biosci; 2021; 8():659687. PubMed ID: 34041265
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 protease flaps spontaneously close to the correct structure in simulations following manual placement of an inhibitor into the open state.
Hornak V; Okur A; Rizzo RC; Simmerling C
J Am Chem Soc; 2006 Mar; 128(9):2812-3. PubMed ID: 16506755
[TBL] [Abstract][Full Text] [Related]
17. Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site.
Sadiq SK; Wan S; Coveney PV
Biochemistry; 2007 Dec; 46(51):14865-77. PubMed ID: 18052195
[TBL] [Abstract][Full Text] [Related]
18. Crucial roles of the subnanosecond local dynamics of the flap tips in the global conformational changes of HIV-1 protease.
Li D; Ji B; Hwang K; Huang Y
J Phys Chem B; 2010 Mar; 114(8):3060-9. PubMed ID: 20143801
[TBL] [Abstract][Full Text] [Related]
19. Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: flap dynamics and binding mechanism.
Meher BR; Wang Y
J Mol Graph Model; 2015 Mar; 56():60-73. PubMed ID: 25562662
[TBL] [Abstract][Full Text] [Related]
20. Gating and Intermolecular Interactions in Ligand-Protein Association: Coarse-Grained Modeling of HIV-1 Protease.
Kang M; Roberts C; Cheng Y; Chang CE
J Chem Theory Comput; 2011 Oct; 7(10):3438-46. PubMed ID: 26598172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
